Capital Research Global Investors Raises Stock Holdings in Addus HomeCare Corporation $ADUS

Capital Research Global Investors boosted its holdings in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 22.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,469,752 shares of the company’s stock after purchasing an additional 268,192 shares during the quarter. Capital Research Global Investors owned approximately 7.95% of Addus HomeCare worth $157,837,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Hohimer Wealth Management LLC boosted its position in Addus HomeCare by 3.4% during the third quarter. Hohimer Wealth Management LLC now owns 2,709 shares of the company’s stock worth $320,000 after purchasing an additional 88 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its position in Addus HomeCare by 2.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after purchasing an additional 103 shares in the last quarter. ProShare Advisors LLC boosted its position in Addus HomeCare by 3.1% during the fourth quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock worth $379,000 after purchasing an additional 105 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its position in Addus HomeCare by 0.6% during the second quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock worth $2,150,000 after purchasing an additional 106 shares in the last quarter. Finally, State of Wyoming boosted its position in Addus HomeCare by 25.7% during the fourth quarter. State of Wyoming now owns 523 shares of the company’s stock worth $56,000 after purchasing an additional 107 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $90.71 on Tuesday. Addus HomeCare Corporation has a one year low of $87.95 and a one year high of $124.43. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.83 and a current ratio of 1.83. The stock has a market cap of $1.69 billion, a PE ratio of 16.77, a P/E/G ratio of 1.26 and a beta of 0.89. The stock has a 50 day moving average price of $93.83 and a 200 day moving average price of $103.76.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, May 4th. The company reported $1.62 EPS for the quarter, beating the consensus estimate of $1.52 by $0.10. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The firm had revenue of $363.50 million during the quarter, compared to analysts’ expectations of $366.41 million. During the same quarter last year, the firm earned $1.42 earnings per share. The business’s revenue for the quarter was up 7.7% on a year-over-year basis. Equities research analysts expect that Addus HomeCare Corporation will post 6.24 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently weighed in on ADUS. Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Wednesday, February 25th. Wall Street Zen downgraded Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a research note on Monday, May 18th. Weiss Ratings downgraded Addus HomeCare from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, May 22nd. Finally, Stephens reduced their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $131.22.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.